FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NYSE:VZ

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

Verizon Communications Inc. (NYSE:VZ) is a holding company. Verizon through its subsidiaries is a provider of communications services. The Company has two segments: Domestic Wireless and Wireline. Verizon Communications Inc. achieved its new 52 week high price of $39.35 where it was opened at $39.11 UP +0.58 points or +1.50% by closing at $39.21.

Verizon Communications Inc. (Verizon) is a holding company. Verizon through its subsidiaries is a provider of communications services. Verizon Communications Inc (NYSE:VZ) achieved its new price of $39.10 where it was opened at $38.79 down -0.15 points or -0.39% by closing at $38.63.

Tags:

Verizon Communications Inc (NYSE:VZ) achieved its new price of $38.78 where it was opened at $38.61 up 0.36 points or +0.94% by closing at $38.78. VZ transacted shares during the day were over 19.88 million shares however it has an average volume of 12.87 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6929

Tags:

Verizon Communications Inc (NYSE:VZ) achieved its new price of $38.59 where it was opened at $38.46 down -0.09 points or -0.23% by closing at $38.26. VZ transacted shares during the day were over 11.85 million shares however it has an average volume of 13.19 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6880

Tags:

Verizon Communications Inc (NYSE:VZ) achieved its new 52 week high price of $14.11 where it was opened at $14.19 UP 0.08 points or +0.21% by closing at $37.85. VZ transacted shares during the day were over 14.11 million shares however it has an average volume of 14.19 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6768

Tags:

The Bank of New York Mellon Corporation (NYSE:BK) reported fourth quarter income from continuing operations applicable to common shareholders of $690 million, or $0.55 per common share, compared with $712 million, or $0.59 per common share, in the fourth quarter of 2009 and $625 million, or $0.51 per common share, in the third quarter of 2010.

Power3 Medical Products, Inc. (PWRM.OB) previously reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

Pages

ADVERTISE WITH US